Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to find the safest dose level of an approved drug, carfilzomib, in solid tumors when given over a different period of time than normally used. The study will also use markers in blood from routine blood draws to help check the levels of the drug. Lastly, the study will check how well this drug works with regards to keeping cancer cells from growing with the new time frame of delivery.
Epistemonikos ID: 2c2d656af536625554886ed4fd5c699db215c320
First added on: May 12, 2024